New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 15, 2014
17:02 EDTNDLS, EPB, EBAY, CSCO, M, RRGB, KMR, AMZN, KMI, ICPT, SEAS, KMP, KATE, JCP, WMTStocks end week slightly higher despite flare-up in Russian tensions
Stocks on Wall Street were higher for the week as earnings season wound down and geopolitical events, primarily in Russia, took center stage once again. MACRO NEWS: In the U.S., the NFIB's small business confidence index rose 0.7% to 95.7 in July, though that was below the expectation for a 96.0 reading. Retail sales were flat in July, versus an expected 0.2% increase. Initial jobless claims rose to 311K in the second week of August, versus expectations for 295K claims. Import prices fell 0.2%, while export prices were flat in July. The Producer Price Index increased 0.1% overall, matching expectations. The first University of Michigan consumer confidence reading for August fell 2.6 points to 79.2, versus expectations for it to have edged up to 82.0. In Europe, growth in the shared currency zone stagnated, with Q2 GDP slipping to unchanged. The biggest economy in the region, Germany, saw its GDP contract 0.2% in the quarter. In Asia, a measure of new credit in China came in at $44.3B in July, marking its lowest monthly total since October 2008. China's industrial production grew 9.0% year-over-year in the month, versus expectations for 9.2% growth. Japan's second quarter GDP fell an annualized 6.8%, which was slightly better than the expectation for a 7% decline. COMPANY NEWS: Wal-Mart (WMT) reported second quarter results that were in-line with expectations, but the world's largest retailer cut its fiscal year earnings outlook citing additional investments in e-commerce and higher U.S. health-care costs than previously anticipated. Despite the lowered guidance, Wal-Mart shares finished the day that it reported up about 0.5%, but the stock lost about 1% for the week. Among the other noteworthy losers following their earnings reports were Macy's (M), J.C. Penney (JCP), Kate Spade (KATE), SeaWorld (SEAS), King Digital (KING), Red Robin Gourmet Burgers (RRGB), and Noodles & Company (NDLS)... Cisco Systems (CSCO) reported higher than expected sales and profits for its fiscal fourth quarter. However, the Dow Jones Industrial Average component declined on the day after its report after saying it does not expect emerging markets growth for "several quarters" and that it expects to cut 6,000 jobs, or 8% of its workforce... Shares of Kinder Morgan (KMI) advanced after the company announced plans to consolidate its oil-and-gas holdings into one company by acquiring all of the outstanding shares of a number of its subsidiaries, including Kinder Morgan Energy Partners (KMP), Kinder Morgan Management (KMR) and El Paso Pipeline Partners (EPB)... Amazon.com (AMZN) advanced after the company launched "Amazon Local Register," a credit-card device and mobile app to help small business owners accept payments that will go head-to-head with competing systems from Square and eBay's (EBAY) PayPal unit... Intercept Pharmaceuticals (ICPT) rose after data from a trial of its liver disease drug OCA showed improved safety as well as a statistical benefit in reversing liver fibrosis. INDEXES: For the week, the Dow gained about 0.66% to close at 16,62.91; the S&P 500 rose about 1.21% to close at 1,955.06; the Nasdaq advanced about 2.14% to close at 4,464.93.
News For WMT;M;JCP;KMI;CSCO;KATE;AMZN;EBAY;KMP;KMR;EPB;SEAS;RRGB;NDLS;ICPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
November 11, 2014
06:03 EDTAMZNQ4 global tablet shipments estimated at 74.5M units, DigiTimes reports
Subscribe for More Information
November 10, 2014
16:00 EDTWMTOptions Update; November 10, 2014
Subscribe for More Information
15:57 EDTEBAYWorldwide Business Research to hold a conference
ProcureCon for Digital & Marketing Services 2014 is being held in San Antonio on November 11-13.
15:44 EDTAMZNAmazon Web Services to hold a conference
Subscribe for More Information
15:29 EDTCSCOCisco November volatility increases into Q1 and outlook
Subscribe for More Information
13:05 EDTJCPJ.C. Penney November volatility elevated into Q3 and holiday outlook
Subscribe for More Information
12:36 EDTWMT, JCPAbercrombie, American Eagle sink after analyst downgrades
Shares of specialty teen apparel retailers Abercrombie & Fitch (ANF) and American Eagle Outfitters (AEO) are falling after a number of analysts issued negative notes on the companies. WHAT'S NEW: Oppenheimer analyst Anna Andreeva downgraded Abercrombie & Fitch to Perform from Outperform. The company's earnings outlook has become less clear as its U.S. brand has not yet become popular, and retail brand turnarounds usually take awhile, Oppenheimer analyst Anna Andreeva wrote in a note to investors. Additionally, Abercrombie's international business, which has deteriorated further this year, faces "mounting uncertainty, the analyst stated. The analyst slashed her price target on the name to $30 from $50. Meanwhile, Barclays analyst Matthew McClintock downgraded American Eagle Outfitters to Equal Weight from Overweight. McClintock has become more pessimistic about the outlook for American Eagle's comparative store sales in the second half of 2014, given recent data points from a number of retailers, including Abercrombie & Fitch, Kohl's (KSS), Wal-Mart (WMT), J.C. Penney (JCP), and Ann Inc. (ANN). The analyst said he saw no reason why American Eagle should significantly outperform the overall apparel sector. McClintock cut his price target on the name to $11 from $15. Meanwhile, the analyst lowered his rating on the Softline Retail sector to Negative from Positive, as he believes that the sector, which includes companies that sell products like apparel, towels, and jewelry - is facing structural difficulties that are likely to persist for the next several years. Separately, research firm Janney Capital downgraded Abercrombie to Neutral from Buy in a note to investors today. PRICE ACTION: In early afternoon trading, Abercrombie & Fitch sank 3.5% to $28.50 and American Eagle dropped 4% to $12.40.
10:17 EDTKATEOptions with decreasing implied volatility
Options with decreasing implied volatility: RMTI ACHN RPRX ARCP SALE ZU KING UBNT KATE AWAY
09:20 EDTJCPOn The Fly: Pre-market Movers
Subscribe for More Information
09:05 EDTKMI, KMR, KMP, EPBKinder Morgan says ISS, Egan-Jones recommend approval of merger transactions
Subscribe for More Information
09:00 EDTWMTWal-Mart weekly volatility increases into Q3 and holiday outlook
Subscribe for More Information
08:36 EDTICPTIntercept price target lowered to $125 from $172 at FBR Capital
FBR Capital lowered its price target for Intercept shares to $125 saying its talks with experts and cardiologists indicate the company's OCA drug is unlikely to be a "silver bullet" for the treatment of nonalcoholic steatohepatitis. FBR notes that while OCA appears to improve the liver, the drug worsens many of the other derangements like lipid and glucose homeostasis. FBR decreased the probability of success in NASH to 55% from 60%, and lowered its peak OCA sales estimate to $5.2B. It keeps an Underperform rating on Intercept shares.
08:23 EDTWMTWal-Mart expectations appear muted heading into earnings, says RW Baird
Subscribe for More Information
08:22 EDTCSCONetwork equipment makers slip after AT&T projects lower 2015 capital spending
Subscribe for More Information
07:12 EDTM, CSCOCA Technologies to hold a conference
CA World 2014 is being held in Las Vegas on November 9-12.
November 9, 2014
18:41 EDTWMTWal-Mart to focus on food safety in China, Reuters says
Subscribe for More Information
16:55 EDTWMTWal-Mart China sales impacted by country's austerity program, WSJ says
Subscribe for More Information
11:56 EDTICPTIntercept announces additional data for OCA in primary biliary cirrhosis
Intercept Pharmaceuticals announced new analyses of data from clinical trials on obeticholic acid, OCA, in patients with primary biliary cirrhosis, PBC. Six posters, including posters with new analyses of data from POISE the first Phase 3 trial in PBC in two decades are being presented at today's poster session at the American Association for the Study of Liver Disease, AASLD, Annual Meeting. OCA, Intercept's lead product candidate, is a bile acid analog and first-in-class agonist of the farnesoid X receptor, FXR, in development for PBC, nonalcoholic steatohepatitis, NASH, primary sclerosing cholangitis, PSC, and other chronic liver diseases.
November 8, 2014
20:20 EDTJCPJ.C. Penney could drop 35%, Barron's says
J.C. Penney shares could drop 35% if the company misses on sales growth estimates, Barron's contends in a feature article. Reference Link
14:03 EDTAMZNJefferies software and internet analysts hold a dinner meeting
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use